nitazoxanide has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Han, D; Hou, X; Liu, H; Liu, Z; Ma, J; Peng, F; Shen, C; Shu, M; Wang, K; Wang, L; Wang, X; Wu, J; Yang, G; Yin, Z; Zhang, D; Zhao, B; Zhao, S; Zhao, W; Zheng, Z; Zhong, C | 1 |
1 other study(ies) available for nitazoxanide and Astrocytoma, Grade IV
Article | Year |
---|---|
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Chloroquine; Glioblastoma; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Growth Protein 1; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthyridines; Nitro Compounds; Protein Processing, Post-Translational; Thiazoles; Transcription, Genetic; Up-Regulation | 2018 |